| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/13/1999 | CN1041633C Novel 2-thiosubstituted carbapenems |
| 01/13/1999 | CN1041631C Novel carbocyclic nucleoside agents useful as selective inhititors of proinflammatory cell factor |
| 01/12/1999 | US5859257 Isoxazole compounds as cyclooxygenase inhibitors |
| 01/12/1999 | US5859256 Chlorination; useful as antibacterial agents and in treating diseases caused by organisms which are resistant to beta-lactam antibiotics |
| 01/12/1999 | US5859238 Reacting crude clavulanic acid extract in organic solvent with alkylenediamine to form diammonium salt, isolating, reacting with potassium 2-ethylhexanaote in isopropanol to form potassium clavulanate |
| 01/12/1999 | US5859219 Isolated nucleotide sequences used for detection of infection as primers for amplification and probes for hybridization; antiulcer agents; anticancer agents |
| 01/12/1999 | US5859187 Inhibit the ul42 stimulation of the herpes virus dna polymerase activity |
| 01/12/1999 | US5859062 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/12/1999 | US5859049 Calanolide and related antiviral compounds, compositions, and uses thereof |
| 01/12/1999 | US5859041 Substituted imidazoles having cytokine inhibitory activity |
| 01/12/1999 | US5859030 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria |
| 01/12/1999 | US5859027 Antimicrobial agent |
| 01/12/1999 | US5859021 Antiviral combinations |
| 01/12/1999 | US5859015 N-heterocyclic piperazinyl and H-heterocyclic piperazinonyl inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859012 Inhibitors of farnesyl-protein transferase |
| 01/12/1999 | US5859011 Dihydropyridine derivatives as bradykinin antagonist |
| 01/12/1999 | US5859009 Substituted spiroalkylamino and alkoxy heterocycles, processes for their preparation, and their use as pesticides and fungicides |
| 01/12/1999 | US5859002 HIV protease inhibitors |
| 01/12/1999 | US5858986 Converting erythromycin a into its 9-oxime derivative; protecting 2' and 4? hydroxy groups; methylation; deprotecting and deoximating; treating with solvent; isolation; drying |
| 01/12/1999 | US5858974 Anti-fungal peptides |
| 01/12/1999 | US5858962 Composition for treating mastitis and other staphylococcal infections |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858729 Preparation of glycosylated open reading frames 3 and 4 of protein associated with mystery swine disease, by co-infecting, culturing, harvesting eukaryotic cells with subgenomic dna fragments in viral vectors |
| 01/12/1999 | US5858727 Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms |
| 01/12/1999 | US5858720 Hiss |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858677 Protein D--an IgD-binding protein of haemophilus influenzae |
| 01/12/1999 | US5858643 Red blood cell composition containing vitamin E or derivatives thereof which exhibits reduced potassium ion leakage after a photoinactivation process |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858369 Anti-acids secretory recombinant BCG vaccine |
| 01/12/1999 | US5858368 Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein |
| 01/12/1999 | US5858366 Immunogenic peptides, antibodies and uses thereof relating to CD4 receptor binding |
| 01/12/1999 | US5858362 Polysaccharide-protein |
| 01/12/1999 | US5858352 Culture medium contains bile acids or salts, air or gas mixtures to mimic the intestinal environment, and divalent cation chelators; enteric pathogens of shigella species flexneri, sonnei, dysentariae, and bodydii |
| 01/12/1999 | CA2151890C Quinoline carboxylic acid derivatives having 7-(4-aminomethyl-3-oxime)pyrrolidine substituent and processes for preparing thereof |
| 01/12/1999 | CA2104917C Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 01/12/1999 | CA1340316C 8-alkoxyquinolonecarboxylic acid salts thereof excellent in the selecti ve toxicity and process of preparing the same |
| 01/10/1999 | CA2236493A1 Mura |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000413A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 01/07/1999 | WO1999000412A1 Interferon stimulating protein and uses thereof |
| 01/07/1999 | WO1999000394A1 Calixarene tubes as cation receptors |
| 01/07/1999 | WO1999000393A1 Quinolone carboxylic acid derivatives |
| 01/07/1999 | WO1998046270A3 Polymeric conjugates polyvalently presenting an agent for therapy |
| 01/07/1999 | WO1998044094A3 Helicobacter aliphatic amidase polypeptides, dna sequences encoding those polypeptides and uses thereof |
| 01/07/1999 | WO1998042740A3 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/07/1999 | WO1998042321A3 Liquid compositions comprising lamivudine |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | WO1998028333A3 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0889052A2 Immunoreactive peptides from Epstein-Barr virus |
| 01/07/1999 | EP0889036A1 HIV protease inhibitors |
| 01/07/1999 | EP0888453A1 Clostridium perfringens vaccines |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888368A1 Polyvalent polymers for the treatment of rotavirus infection |
| 01/07/1999 | EP0888360A1 Penicillin glycolate |
| 01/07/1999 | EP0888352A1 Fused imidazole derivatives as multidrug resistance modulators |
| 01/07/1999 | EP0888322A2 Electrophilic ketones for the treatment of herpesvirus infections |
| 01/07/1999 | EP0888309A1 Imidazole derivatives having affinity for alpha2 receptors activity |
| 01/07/1999 | EP0888138A1 Topical formulations for the treatment of nail psoriasis |
| 01/07/1999 | EP0888128A2 Delivery of exogenous compounds |
| 01/07/1999 | EP0888124A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 01/07/1999 | EP0888122A1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 01/07/1999 | EP0888120A1 Hla binding peptides and their uses |
| 01/07/1999 | EP0888062A1 Antibacterially active marine algae extracts from the class diatomatae and methods of use |
| 01/07/1999 | EP0651818B1 Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 01/07/1999 | DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide |
| 01/06/1999 | CN1204367A Antifungal proteins |
| 01/06/1999 | CN1204366A Antifungal protein |
| 01/06/1999 | CN1204344A Transferrin receptor protein of Moraxella |
| 01/06/1999 | CN1204336A Cephalosporin antibiotics |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1203807A Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/06/1999 | CN1203790A Medicine for curing and operating purpose and its preparing method |
| 01/06/1999 | CN1041524C Oligopeptides derived from C-reactive protein fragments and its medical composition |
| 01/05/1999 | US5856515 Electron-deficient porphyrins and processes and intermediates for preparing same |
| 01/05/1999 | US5856503 Anticholesterol agents |
| 01/05/1999 | US5856364 Mixture of pyruvate salt, antioxidant and fatty acid |
| 01/05/1999 | US5856355 Pharmaceutical composition |
| 01/05/1999 | US5856353 Sulfonamide inhibitors of aspartyl protease |
| 01/05/1999 | US5856347 Antibacterial preparation or bactericide comprising 2-aminothiazole derivative and/or salt thereof |
| 01/05/1999 | US5856330 Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| 01/05/1999 | US5856321 Preparation of carbapenems |
| 01/05/1999 | US5856320 Antibiotic resistant stapylococcus |
| 01/05/1999 | US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 01/05/1999 | US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/05/1999 | US5856151 Antifungal preparations containing osmotin |